JOHNSON & JOHNSON

Trading Ideas Johnson & Johnson Borsa Italiana

Equities

4JNJ

US4781601046

Real-time Estimate Tradegate Other stock markets 03:48:47 2024-07-17 am EDT			5-day change	1st Jan Change
139.1 ^EUR	+0.80%		+1.86%	-1.88%

Jul. 16	ORIC Pharmaceuticals, Inc. Enters into Clinical Trial Collaboration and Supply Agreements with Bayer and Janssen Research & Development, LLC	CI
Jul. 16	EQT Unit Invests in Biotechnology Company Asceneuron	MT

Trading Ideas

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

JOHNSON & JOHNSON :An end to the technical rebound lies ahead	19-11-27
JOHNSON & JOHNSON :The underlying trend is to the upside	17-06-12
JOHNSON & JOHNSON :Expect the comeback of a strong trend	17-05-10
JOHNSON & JOHNSON :Buying pressure	16-12-22
JOHNSON & JOHNSON :A good level to buy	16-09-12
JOHNSON & JOHNSON :Towards historic highs	12-09-26
JOHNSON & JOHNSON :Beginning of a bearish movement	12-06-26

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 12:30 pm EST

Protect and grow your investments with the help of our experts

Secure my Investments

fermer